ATF4 and Huntington disease: Treatment of HD cells with monensin, a Golgi stress inducer, resulted in activation of PERK-ATF4-CSE pathway and subsequent increase of H2S and protein persulfidation leading to the better resistance of those cells to oxidants (Sbodio et al., 2018).